COVID-19 Patients With Adequate Levels Of Vitamin D Have Less Complications And Lower Mortality According To Iranian Study. Canadian Study Says Otherwise!
: Researchers from Tehran University of Medical Sciences and Sina Hospital-Tehran have found that hospitalized COVID-19 patients with adequate blood levels of Vitamin D exhibited lesser complications and also had a lower mortality risk.
The study results were published in the peer-reviewed journal: PLOS One https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0239799
In the study, hospitalized COVID-19 patients who were vitamin D sufficient, with a blood level of 25-hydroxyvitamin D of at least 30 ng/mL (a measure of vitamin D status), had a significant decreased risk for adverse clinical outcomes including becoming unconscious, hypoxia (body starved for oxygen) and death. In addition, they had lower blood levels of an inflammatory marker (C-reactive protein) and higher blood levels of lymphocytes (a type of immune cell to help fight infection).
Corresponding author Dr Michael F. Holick, Ph.D., MD, Professor of medicine, physiology and biophysics and molecular medicine at Boston University School of Medicine told Thailand Medical News, "This study provides direct evidence that vitamin D sufficiency can reduce the complications, including the cytokine storm (release of too many proteins into the blood too quickly) and ultimately death from COVID-19.”
For the study, a blood sample to measure vitamin D status (measured serum level of 25-hydroxyvitamin D) was taken from 235 patients were admitted to the hospital with COVID-19.
The patients were followed for clinical outcomes including clinical severity of the infection, becoming unconscious, having difficulty in breathing resulting in hypoxia and death. The blood was also analyze for an inflammatory marker (C-reactive protein) and for numbers of lymphocytes.
The study team then compared all of these parameters in patients who were vitamin D deficient to those who were vitamin D sufficient.
It was observed that in patients older than 40 years, those who were vitamin D sufficient were 51.5 percent less likely to die from the infection compared to patients who were vitamin D deficient or insufficient with a blood level of 25-hydroxyvitamin D less than 30 ng/mL.
Dr Holick, who most recently published a study which found that a sufficient amount of vitamin D can reduce the risk of catching coronavirus by 54 percent, believes that being vitamin D sufficient helps to fight consequences from being infected not only with the corona virus but also other viruses causing upper respiratory tract illnesses including influenza.
He added, "There is great concern that the combination of an influenza infection and a coronal viral infection could substantially increase hospitalizations and death due to complications from these viral infections."
This study provides a simple and cost-effective strategy to improve one's ability to fight the corona virus and reduce COVID-19's adverse clinical outcomes, including requiring ventilator support, overactive immune response leading to cytokine storm and death.
He commented, "Because vitamin D deficiency and insufficiency is so widespread in children and
adults in the United States and worldwide, especially in the winter months, it is prudent for everyone to take a vitamin D supplement to reduce risk of being infected and having complications from COVID-19."
There are already numerous studies showing the importance of Vitamin D in COVID-19 since Thailand Medical News first wrote about the effectiveness of Vitamin D in early May. https://www.thailandmedical.news/news/covid-19-supplements-new-study-shows-vitamin-d-could-be-linked-to-covid-19-mortality-and-infection-rates
However there are some researchers that are being backed by big pharma giants discreetly are to try to discredit studies on Vitamin D as it does not help them in their cause to introduce expensive ineffective drugs to boost their profitability.
Recently a Professor of pediatrics from the University of Alberta in Canada said that there is little evidence that taking vitamin D prevents severe COVID-19.
The same Canadian university is heavily engrossed in trying to find ways to boost Gilead’s expensive drug remdesivir that so far has no long term safety studies and has been given U.S. FDA EUA approval based only on the flimsy fact that it reduced hospitalization stays. With many frontline doctors now reporting dismal performance by the overpriced drug, the University of Alberta is helping to find ways to boost remdesivir acceptance! The University research is backed by Gilead! https://www.folio.ca/u-of-a-lab-uncovers-new-mechanism-of-action-against-sars-cov-2-by-antiviral-drug-remdesivir/?fbclid=IwAR16ixst8UZ9Z4u0mg-Mjls-dpQ-NUBadUBtSZnsZTY7iC369-rM-_Fgrko
Hence all research from that university should be on a watchlist and also the credibility of any research from that university should be questioned.
For more on COVID-19-Vitamin D
, keep on logging to Thailand Medical News.